Literature DB >> 12548106

Risk factors for gallbladder cancer: a reappraisal.

M Pandey1.   

Abstract

Carcinoma of the gallbladder has a very unusual geographical distribution with pockets of high incidence seen in Chile, Poland, India, Japan and Israel; it occurs rarely in the rest of the world. It is a common malignancy in the Western Bihar and Eastern Uttar Pradesh regions of India. Patients present with extremes of clinical symptoms, indicating benign biliary diseases on the one hand and incurable malignant disease on the other. Laboratory and roentgenographic data tend to confirm the clinical diagnosis of the advanced incurable disease at presentation, in most cases. Various aetiopathological agents have been proposed but none has stood the test of time. In this article, we have reviewed the aetiopathological agents proposed from time to time over the past two centuries, with special emphasis on the developments made in the last 25 years.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12548106     DOI: 10.1097/00008469-200302000-00004

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  25 in total

1.  Gallbladder cancer: the basics.

Authors:  Eldon A Shaffer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-10

2.  A Comparative Analysis of Clinical Characteristics and Histomorphologic and Immunohistochemical Spectrum of Gallbladder Carcinoma in Young Adults (< 45 Years) and Elderly Adults (> 60 Years).

Authors:  Suneeta Gupta; Hanni V Gulwani; Sukhpreet Kaur
Journal:  Indian J Surg Oncol       Date:  2020-02-06

3.  Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary.

Authors:  Masayuki Nagahashi; Yoichi Ajioka; Istvan Lang; Zoltan Szentirmay; Miklos Kasler; Hiroto Nakadaira; Naoyuki Yokoyama; Gen Watanabe; Ken Nishikura; Toshifumi Wakai; Yoshio Shirai; Katsuyoshi Hatakeyama; Masaharu Yamamoto
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

4.  Cytologic diagnosis of gallbladder lesions - A study of 150 cases.

Authors:  Uma Handa; Annu Nanda; Harsh Mohan; Suman Kochhar; Atul Sachdev
Journal:  Indian J Surg       Date:  2010-08-26       Impact factor: 0.656

5.  Adjuvant chemoradiotherapy for squamous cell carcinoma of gallbladder.

Authors:  Supriya Mallick; Rony Benson; P K Julka; Goura Kishor Rath
Journal:  J Gastrointest Cancer       Date:  2014-12

6.  T2 gallbladder cancer shows substantial survival variation between continents and this is not due to histopathologic criteria or pathologic sampling differences.

Authors:  Mia S DeSimone; Michael Goodman; Burcin Pehlivanoglu; Bahar Memis; Serdar Balci; Juan Carlos Roa; Kee-Taek Jang; Jin-Young Jang; Seung-Mo Hong; Kyoungbun Lee; Haeryoung Kim; Hye-Jeong Choi; Takashi Muraki; Juan Carlos Araya; Enrique Bellolio; Juan M Sarmiento; Shishir K Maithel; Hector F Losada; Olca Basturk; Michelle D Reid; Jill Koshiol; Volkan Adsay
Journal:  Virchows Arch       Date:  2021-01-07       Impact factor: 4.064

Review 7.  Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis.

Authors:  Kshitij Srivastava; Anvesha Srivastava; Kiran Lata Sharma; Balraj Mittal
Journal:  Mutat Res       Date:  2011-06-25       Impact factor: 2.433

8.  Squamous cell carcinoma of the gallbladder.

Authors:  Fahmi Mghirbi; Mouna Ayadi; Wafa Karray; Yosra Yahyaoui; Khedija Meddeb; Amina Mokrani; Henda Raies; Nesrine Chraeit; Amel Mezlini
Journal:  Transl Gastroenterol Hepatol       Date:  2016-10-20

Review 9.  Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?

Authors:  Eldon A Shaffer
Journal:  Curr Gastroenterol Rep       Date:  2005-05

10.  Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study.

Authors:  Marcelo E Andia; Ann W Hsing; Gabriella Andreotti; Catterina Ferreccio
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.